Argatroban is a direct thrombin inhibitor used as an anticoagulant primarily in patients with heparin-induced thrombocytopenia (HIT) to prevent and treat thrombosis. It is administered intravenously and requires careful monitoring of activated partial thromboplastin time (aPTT) to ensure therapeutic efficacy and safety.